NAS:CNST (USA)
Constellation Pharmaceuticals Inc $ 25.94 0.78 (3.1%)
Volume:
379,094
Avg Vol (1m):
487,263
Market Cap $:
1.24 Bil
Enterprise Value $:
824.18 Mil
PE Ratio:
0.00
PB Ratio:
2.99
Financial Strength | 5/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 99.73 | ||
Debt-to-Equity | 0.01 | ||
Debt-to-EBITDA | -0.03 | ||
Piotroski F-Score | 3 | ||
Altman Z-Score | 0 | ||
Beneish M-Score | 0 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -31.93 | ||
ROA % | -28.03 | ||
ROC (Joel Greenblatt) % | -1268.82 | ||
3-Year EBITDA Growth Rate | 55.6 | ||
3-Year EPS without NRI Growth Rate | 6.2 |
CNST
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 2.99 | ||
EV-to-EBIT | -6.68 | ||
EV-to-EBITDA | -6.7 | ||
Current Ratio | 14.03 | ||
Quick Ratio | 14.03 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -245.7 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 3.01 | ||
Earnings Yield (Greenblatt) % | -14.98 |